Amyloid processing in COVID-19-associated neurological syndromes.
Saved in:
| Title: | Amyloid processing in COVID-19-associated neurological syndromes. |
|---|---|
| Authors: | Ziff OJ; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; Francis Crick Institute, London, UK., Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; King's College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK., Mehta PR; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK., Brown R; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; Institute of Immunity and Transplantation, University College London, London, UK., Athauda D; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; Francis Crick Institute, London, UK., Heaney J; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; Advanced Pathogens Diagnostic Unit, University College London Hospitals NHS Foundation Trust, London, UK., Heslegrave AJ; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; UK Dementia Research Institute, University College London, London, UK., Benedet AL; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Checkley AM; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; Advanced Pathogens Diagnostic Unit, University College London Hospitals NHS Foundation Trust, London, UK., Houlihan CF; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; Advanced Pathogens Diagnostic Unit, University College London Hospitals NHS Foundation Trust, London, UK., Gauthier S; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Montreal, Canada.; Alzheimer's Disease Research Unit, Montréal, Canada.; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Canada., Rosa-Neto P; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Montreal, Canada.; Alzheimer's Disease Research Unit, Montréal, Canada.; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Canada., Fox NC; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; UK Dementia Research Institute, University College London, London, UK., Schott JM; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK., Zetterberg H; Queen Square Institute of Neurology, University College London, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; UK Dementia Research Institute, University College London, London, UK., Benjamin LA; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; University of Liverpool, Brain Infections Group, Merseyside, Liverpool, UK.; Laboratory of Molecular and Cell Biology, UCL, London, UK., Paterson RW; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.; UK Dementia Research Institute, University College London, London, UK.; Darent Valley Hospital, Kent, UK. |
| Source: | Journal of neurochemistry [J Neurochem] 2022 Apr; Vol. 161 (2), pp. 146-157. Date of Electronic Publication: 2022 Mar 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley on behalf of the International Society for Neurochemistry Country of Publication: England NLM ID: 2985190R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-4159 (Electronic) Linking ISSN: 00223042 NLM ISO Abbreviation: J Neurochem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-4159 |
|---|---|
| DOI: | 10.1111/jnc.15585 |
